{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T03:09:33Z","timestamp":1785294573033,"version":"3.55.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014867","name":"University of Bern Department of Clinical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014867","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jacc.2026.05.028","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T14:36:25Z","timestamp":1785249385000},"page":"437-450","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Timing, Translation, and Preparedness"],"prefix":"10.1016","volume":"88","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8775-0511","authenticated-orcid":false,"given":"Tobias","family":"Tritschler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"Fuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick R.","family":"Lawler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Farkouh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina E.","family":"Marx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Neal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Sholzberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex C.","family":"Spyropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven Y.C.","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Mu\u00f1oz-Rivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Blondon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1428-879X","authenticated-orcid":false,"given":"Behnood","family":"Bikdeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Cattaneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Cushman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Goldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewan C.","family":"Goligher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5889-5981","authenticated-orcid":false,"given":"Judith S.","family":"Hochman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"J\u00fcni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe K.","family":"McQuilten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuccia","family":"Morici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9602-0513","authenticated-orcid":false,"given":"Parham","family":"Sadeghipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balasubramanian","family":"Venkatesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Zuily","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Amstutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drahomir","family":"Aujesky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8296-2972","authenticated-orcid":false,"given":"Marc","family":"Carrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin V.","family":"Hofstetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas","family":"Murthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Rodger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Skeith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Areti A.","family":"Veroniki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Hutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Zarychanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3416-8210","authenticated-orcid":false,"given":"Gregg W.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9goire","family":"Le Gal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jacc.2026.05.028_bib1","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDctcs2300291","article-title":"Lessons Learned from National Heart, Lung, and Blood Institute Covid-19 Clinical Trials","volume":"3","author":"Thomas","year":"2024","journal-title":"NEJM Evid"},{"issue":"40","key":"10.1016\/j.jacc.2026.05.028_bib2","doi-asserted-by":"crossref","first-page":"E1156","DOI":"10.1503\/cmaj.201240","article-title":"Anticipating and managing coagulopathy and thrombotic manifestations of severe COVID-19","volume":"192","author":"Godoy","year":"2020","journal-title":"CMAJ"},{"issue":"23","key":"10.1016\/j.jacc.2026.05.028_bib3","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1016\/j.jacc.2020.04.031","article-title":"COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review","volume":"75","author":"Bikdeli","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.jacc.2026.05.028_bib4","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/rth2.12372","article-title":"A proposal for staging COVID-19 coagulopathy","volume":"4","author":"Thachil","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"issue":"4","key":"10.1016\/j.jacc.2026.05.028_bib5","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacc.2026.05.028_bib6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","article-title":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb Res"},{"issue":"6","key":"10.1016\/j.jacc.2026.05.028_bib7","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00134-020-06062-x","article-title":"High risk of thrombosis in patients in severe SARS-CoV-2 infection: a multicenter prospective cohort study","volume":"46","author":"Helms","year":"2020","journal-title":"Intensive Care Med"},{"issue":"5","key":"10.1016\/j.jacc.2026.05.028_bib8","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/jth.14817","article-title":"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy","volume":"18","author":"Tang","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.jacc.2026.05.028_bib9","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jacc.2020.05.001","article-title":"Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19","volume":"76","author":"Paranjpe","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.jacc.2026.05.028_bib10","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1111\/jth.14869","article-title":"High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients","volume":"18","author":"Llitjos","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"2","key":"10.1016\/j.jacc.2026.05.028_bib11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/ejh.13533","article-title":"Association of anticoagulation dose and survival in hospitalized COVID-19 patients: A retrospective propensity score-weighted analysis","volume":"106","author":"Ionescu","year":"2021","journal-title":"Eur J Haematol"},{"issue":"11","key":"10.1016\/j.jacc.2026.05.028_bib12","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1111\/jth.15094","article-title":"Anticoagulant interventions in hospitalized patients with COVID-19: A scoping review of randomized controlled trials and call for international collaboration","volume":"18","author":"Tritschler","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"15","key":"10.1016\/j.jacc.2026.05.028_bib13","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/j.jacc.2021.02.035","article-title":"Recent randomized trials of antithrombotic therapy for patients with COVID-19: JACC state-of-the-art review","volume":"77","author":"Talasaz","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.jacc.2026.05.028_bib14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.7326\/ANNALS-24-00800","article-title":"WHO Rapid Evidence Appraisal for COVID-19 Therapies Working Group. Anticoagulation among patients hospitalized for COVID-19: a systematic review and prospective meta-analysis","volume":"178","author":"Vale","year":"2025","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2026.05.028_bib15","series-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.5","author":"Higgins","year":"2024"},{"key":"10.1016\/j.jacc.2026.05.028_bib16","series-title":"Individual Participant Data Meta-Analysis: A Handbook for Healthcare Research","author":"Riley","year":"2021"},{"issue":"16","key":"10.1016\/j.jacc.2026.05.028_bib17","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1001\/jama.2015.3656","article-title":"Preferred reporting items for systematic review and meta-analyses of individual participant data: the PRISMA-IPD statement","volume":"313","author":"Stewart","year":"2015","journal-title":"JAMA"},{"issue":"32","key":"10.1016\/j.jacc.2026.05.028_bib18","doi-asserted-by":"crossref","first-page":"E901","DOI":"10.1503\/cmaj.200077","article-title":"Development of the Instrument to assess the Credibility of Effect Modification Analyses (ICEMAN) in randomized controlled trials and meta-analyses","volume":"192","author":"Schandelmaier","year":"2020","journal-title":"CMAJ"},{"issue":"4","key":"10.1016\/j.jacc.2026.05.028_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060650","article-title":"Individual participant data meta-analysis for a binary outcome: one-stage or two-stage?","volume":"8","author":"Debray","year":"2013","journal-title":"PLoS One"},{"issue":"19","key":"10.1016\/j.jacc.2026.05.028_bib20","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1002\/sim.8555","article-title":"One-stage individual participant data meta-analysis models for continuous and binary outcomes: Comparison of treatment coding options and estimation methods","volume":"39","author":"Riley","year":"2020","journal-title":"Stat Med"},{"key":"10.1016\/j.jacc.2026.05.028_bib21","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.jacc.2026.05.028_bib22","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jclinepi.2010.09.011","article-title":"GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jacc.2026.05.028_bib23","series-title":"Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach","year":"2013"},{"issue":"9","key":"10.1016\/j.jacc.2026.05.028_bib24","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJMoa2105911","article-title":"Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19","volume":"385","author":"Lawler","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2026.05.028_bib25","article-title":"Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial","volume":"375","author":"Sholzberg","year":"2021","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.jacc.2026.05.028_bib26","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1001\/jamainternmed.2021.6203","article-title":"Efficacy and safety of therapeutic-dose heparin vs standard prophylactic or intermediate-dose heparins for thromboprophylaxis in high-risk hospitalized patients with COVID-19: The HEP-COVID randomized clinical trial","volume":"181","author":"Spyropoulos","year":"2021","journal-title":"JAMA Intern Med"},{"issue":"19","key":"10.1016\/j.jacc.2026.05.028_bib27","doi-asserted-by":"crossref","first-page":"5632","DOI":"10.3390\/jcm11195632","article-title":"Efficacy and safety of tinzaparin in prophylactic, intermediate and therapeutic doses in non-critically ill patients hospitalized with COVID-19: the PROTHROMCOVID randomized controlled trial","volume":"11","author":"Munoz-Rivas","year":"2022","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.jacc.2026.05.028_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12712","article-title":"Therapeutic anticoagulation to prevent thrombosis, coagulopathy, and mortality in severe COVID-19: the Swiss COVID-HEP randomized clinical trial","volume":"6","author":"Blondon","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"issue":"2","key":"10.1016\/j.jacc.2026.05.028_bib29","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200293","article-title":"Anticoagulation strategies in non-critically ill patients with Covid-19","volume":"2","author":"McQuilten","year":"2023","journal-title":"NEJM Evid"},{"issue":"18","key":"10.1016\/j.jacc.2026.05.028_bib30","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.jacc.2023.02.041","article-title":"Randomized trial of anticoagulation strategies for noncritically ill patients hospitalized with COVID-19","volume":"81","author":"Stone","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2026.05.028_bib31","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejim.2022.01.031","article-title":"Efficacy and safety of therapeutic vs. prophylactic bemiparin in noncritically ill patients with COVID-19 pneumonia","volume":"99","author":"Varona","year":"2022","journal-title":"Eur J Intern Med"},{"issue":"11","key":"10.1016\/j.jacc.2026.05.028_bib32","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1007\/s00392-023-02240-1","article-title":"Initial therapeutic anticoagulation with rivaroxaban compared to prophylactic therapy with heparins in moderate to severe COVID-19: results of the COVID-PREVENT randomized controlled trial","volume":"112","author":"Rauch-Krohnert","year":"2023","journal-title":"Clin Res Cardiol"},{"issue":"10291","key":"10.1016\/j.jacc.2026.05.028_bib33","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/S0140-6736(21)01203-4","article-title":"Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial","volume":"397","author":"Lopes","year":"2021","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jacc.2026.05.028_bib34","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1055\/a-1667-7534","article-title":"Therapeutic versus prophylactic bemiparin in hospitalized patients with nonsevere covid-19 pneumonia (BEMICOP study): an open-label, multicenter, randomized, controlled trial","volume":"122","author":"Marcos-Jubilar","year":"2022","journal-title":"Thromb Haemost"},{"issue":"6","key":"10.1016\/j.jacc.2026.05.028_bib35","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1001\/jamainternmed.2023.0456","article-title":"Effects of standard-dose prophylactic, high-dose prophylactic, and therapeutic anticoagulation in patients with hypoxemic COVID-19 pneumonia: the ANTICOVID randomized clinical trial","volume":"183","author":"Labb\u00e9","year":"2023","journal-title":"JAMA Intern Med"},{"issue":"9","key":"10.1016\/j.jacc.2026.05.028_bib36","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1161\/CIRCULATIONAHA.121.058113","article-title":"What are adaptive platform clinical trials and what role may they have in cardiovascular medicine?","volume":"145","author":"Lawler","year":"2022","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.jacc.2026.05.028_bib37","doi-asserted-by":"crossref","first-page":"4710","DOI":"10.1182\/bloodadvances.2021005963","article-title":"Emerging clinical trial designs may accelerate translation in hematology: lessons from COVID-19","volume":"6","author":"Neal","year":"2022","journal-title":"Blood Adv"},{"issue":"8","key":"10.1016\/j.jacc.2026.05.028_bib38","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/jth.14929","article-title":"Scientific and standardization committee communication: clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19","volume":"18","author":"Spyropoulos","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"3","key":"10.1016\/j.jacc.2026.05.028_bib39","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.chest.2020.05.559","article-title":"Prevention, diagnosis, and treatment of VTE in patients with coronavirus disease 2019: CHEST guideline and expert panel report","volume":"158","author":"Moores","year":"2020","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.jacc.2026.05.028_bib40","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1182\/bloodadvances.2020003763","article-title":"American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19","volume":"5","author":"Cuker","year":"2021","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.jacc.2026.05.028_bib41","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.chest.2022.02.006","article-title":"Thromboprophylaxis in patients with COVID-19: a brief update to the CHEST guideline and expert panel report","volume":"162","author":"Moores","year":"2022","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.jacc.2026.05.028_bib42","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1111\/jth.15808","article-title":"ISTH guidelines for antithrombotic treatment in COVID-19","volume":"20","author":"Schulman","year":"2022","journal-title":"J Thromb Haemost"},{"issue":"17","key":"10.1016\/j.jacc.2026.05.028_bib43","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1182\/bloodadvances.2022007940","article-title":"American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19: March 2022 update on the use of anticoagulation in critically ill patients","volume":"6","author":"Cuker","year":"2022","journal-title":"Blood Adv"},{"issue":"6","key":"10.1016\/j.jacc.2026.05.028_bib44","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.chest.2022.01.036","article-title":"POINT: should therapeutic heparin be administered to acutely ill hospitalized patients with COVID-19? Yes","volume":"161","author":"Tritschler","year":"2022","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.jacc.2026.05.028_bib45","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.chest.2022.01.037","article-title":"COUNTERPOINT: should therapeutic heparin be administered to acutely ill hospitalized patients with COVID-19? No","volume":"161","author":"Jimenez","year":"2022","journal-title":"Chest"},{"issue":"10320","key":"10.1016\/j.jacc.2026.05.028_bib46","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0140-6736(21)01906-1","article-title":"Studying the coagulopathy of COVID-19","volume":"399","author":"Spyropoulos","year":"2022","journal-title":"Lancet"},{"issue":"7855","key":"10.1016\/j.jacc.2026.05.028_bib48","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","article-title":"The changing landscape of atherosclerosis","volume":"592","author":"Libby","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jacc.2026.05.028_bib49","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/eurheartj\/ehaa099","article-title":"Targeting cardiovascular inflammation: next steps in clinical translation","volume":"42","author":"Lawler","year":"2021","journal-title":"Eur Heart J"},{"issue":"22","key":"10.1016\/j.jacc.2026.05.028_bib50","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1161\/CIRCULATIONAHA.113.007603","article-title":"Time-dependent changes in atherosclerotic plaque composition in patients undergoing carotid surgery","volume":"129","author":"van Lammeren","year":"2014","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.jacc.2026.05.028_bib51","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.jacc.2023.12.024","article-title":"2024 ACC expert consensus decision pathway for treatment of heart failure with reduced ejection fraction: a report of the American College of Cardiology Solution Set Oversight Committee","volume":"83","author":"Maddox","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.jacc.2026.05.028_bib52","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1056\/NEJMoa2512686","article-title":"Beta-blockers after myocardial infarction with normal ejection fraction","volume":"394","author":"Kristensen","year":"2026","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.jacc.2026.05.028_bib53","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1056\/NEJMoa2504735","article-title":"Beta-blockers after myocardial infarction without reduced ejection fraction","volume":"393","author":"Ibanez","year":"2025","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.jacc.2026.05.028_bib54","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1056\/NEJMoa2401479","article-title":"Beta-blockers after myocardial infarction and preserved ejection fraction","volume":"390","author":"Yndigegn","year":"2024","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.jacc.2026.05.028_bib55","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/S2213-2600(21)00356-8","article-title":"Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trial","volume":"9","author":"Ehrmann","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"9","key":"10.1016\/j.jacc.2026.05.028_bib56","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa2103417","article-title":"Therapeutic anticoagulation with heparin in critically ill patients with Covid-19","volume":"385","author":"Goligher","year":"2021","journal-title":"N Engl J Med"}],"container-title":["JACC"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109726066520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109726066520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:02:36Z","timestamp":1785250956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109726066520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0735109726066520"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2026.05.028","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Timing, Translation, and Preparedness","name":"articletitle","label":"Article Title"},{"value":"JACC","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2026.05.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}